These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11865678)

  • 1. Analysis of gene and protein expression for drug mode of toxicity.
    Furness LM
    Curr Opin Drug Discov Devel; 2002 Jan; 5(1):98-103. PubMed ID: 11865678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The promise of toxicogenomics.
    Waring JF; Halbert DN
    Curr Opin Mol Ther; 2002 Jun; 4(3):229-35. PubMed ID: 12139308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression profiling for pharmaceutical toxicology screening.
    Bugelski PJ
    Curr Opin Drug Discov Devel; 2002 Jan; 5(1):79-89. PubMed ID: 11865676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of microarray technologies in toxicology research.
    Vrana KE; Freeman WM; Aschner M
    Neurotoxicology; 2003 Jun; 24(3):321-32. PubMed ID: 12782098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomics: recent applications and new technologies.
    Elrick MM; Walgren JL; Mitchell MD; Thompson DC
    Basic Clin Pharmacol Toxicol; 2006 May; 98(5):432-41. PubMed ID: 16635100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of connectivity mapping in predictive toxicology based on gene-expression similarity.
    Smalley JL; Gant TW; Zhang SD
    Toxicology; 2010 Feb; 268(3):143-6. PubMed ID: 19788908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D-Serine exposure resulted in gene expression changes indicative of activation of fibrogenic pathways and down-regulation of energy metabolism and oxidative stress response.
    Soto A; DelRaso NJ; Schlager JJ; Chan VT
    Toxicology; 2008 Jan; 243(1-2):177-92. PubMed ID: 18061331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microarray expression profiling resources for plant genomics.
    Rensink WA; Buell CR
    Trends Plant Sci; 2005 Dec; 10(12):603-9. PubMed ID: 16275051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel genomic methods for drug discovery and mechanism-based toxicological assessment.
    Gant TW; Zhang SD; Taylor EL
    Curr Opin Drug Discov Devel; 2009 Jan; 12(1):72-80. PubMed ID: 19152215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicogenomics in biomarker discovery.
    Decristofaro MF; Daniels KK
    Methods Mol Biol; 2008; 460():185-94. PubMed ID: 18449488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomics and systems biology--how relevant are the developments to veterinary pharmacology, toxicology and therapeutics?
    Witkamp RF
    J Vet Pharmacol Ther; 2005 Jun; 28(3):235-45. PubMed ID: 15953196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complementary gene and protein expression studies and integrative approaches in toxicogenomics.
    Merrick BA; Madenspacher JH
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):189-94. PubMed ID: 15992845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicogenomics in the pharmaceutical industry: hollow promises or real benefit?
    Lühe A; Suter L; Ruepp S; Singer T; Weiser T; Albertini S
    Mutat Res; 2005 Aug; 575(1-2):102-15. PubMed ID: 15924886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomics and proteomics analysis of cultured primary rat hepatocytes.
    Beigel J; Fella K; Kramer PJ; Kroeger M; Hewitt P
    Toxicol In Vitro; 2008 Feb; 22(1):171-81. PubMed ID: 17768030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA microarray applications in functional genomics.
    Jares P
    Ultrastruct Pathol; 2006; 30(3):209-19. PubMed ID: 16825123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Where are we in genomics?
    Hocquette JF
    J Physiol Pharmacol; 2005 Jun; 56 Suppl 3():37-70. PubMed ID: 16077195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a large-scale chemogenomics database to improve drug candidate selection and to understand mechanisms of chemical toxicity and action.
    Ganter B; Tugendreich S; Pearson CI; Ayanoglu E; Baumhueter S; Bostian KA; Brady L; Browne LJ; Calvin JT; Day GJ; Breckenridge N; Dunlea S; Eynon BP; Furness LM; Ferng J; Fielden MR; Fujimoto SY; Gong L; Hu C; Idury R; Judo MS; Kolaja KL; Lee MD; McSorley C; Minor JM; Nair RV; Natsoulis G; Nguyen P; Nicholson SM; Pham H; Roter AH; Sun D; Tan S; Thode S; Tolley AM; Vladimirova A; Yang J; Zhou Z; Jarnagin K
    J Biotechnol; 2005 Sep; 119(3):219-44. PubMed ID: 16005536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Transcriptomes for serial analysis of gene expression].
    Marti J; Piquemal D; Manchon L; Commes T
    J Soc Biol; 2002; 196(4):303-7. PubMed ID: 12645300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel drug discovery and molecular biological methods, via DNA, RNA and protein changes using structure-function transitions: Transitional structural chemogenomics, transitional structural chemoproteomics and novel multi-stranded nucleic acid microarray.
    Gagna CE; Lambert WC
    Med Hypotheses; 2006; 67(5):1099-114. PubMed ID: 16828979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.